We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Genetic Mutation May Lead to Test for Parkinson's

By HospiMedica staff writers
Posted on 26 Jan 2005
A recently discovered gene that is probably the most common genetic cause of Parkinson's disease, according to two new studies, could lead to the development of a genetic test to detect the mutation in people at risk.

Investigators found that a mutation in the gene LRRK2 appears to occur in at least one of every 60 people who have the disease. More...
Overall, the mutation could be responsible for up to 5% of Parkinson's disease in people with a family history of the disorder, and may account for 1½ -2% of cases in people who do not have a family history of the disease. The researchers found a mutation in one copy of the gene can lead to the disease. These findings were reported in the January 17, 2005, online issue of The Lancet.

"Knowing that this mutation is not only important in familial forms of disease but in typical sporadic disease, where there is no strong family history, could lead to earlier detection of Parkinson's disease,” explained Andrew Singleton, Ph.D., chief of the molecular genetics unit in the Laboratory of Neurogenetics of the U.S. National Institute of Aging (NIA, Bethesda, MD, USA). "Further study of how this gene works also might help scientists identify new treatments.”

LRRK2 was discovered by Dr. Singleton and colleagues. The gene encodes a protein named dardarin from the Basque work dardara, which means tremor, a major symptom of Parkinson's disease. The gene was isolated on a region of chromosome 12 called PARK8 by investigators who studied five families with a history of Parkinson's disease who lived in the Basque region of Spain or in England.




Related Links:
National Institute of Aging

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.